GlucoPredict™ Prepares for Second Pilot of Meal and Portion Education Platform

Established by a long-lasting Type 1 diabetes supporter, GlucoPredict ™ assists users check out culturally varied meals, compare parts, and comprehend prospective glucose effect before the very first bite.

MIAMI – Nov. 4, 2026 – PRLog — GlucoPredict ™ Advances AI Technology to Estimate Post-Meal Glucose Peaks Before Eating

Patent-pending platform integrates AI-powered meal analysis, glucose-response modeling, and part contrasts to support educated diabetes management.

PEMBROKE PINES, FL– November 4, 2026– Metaboliq, Inc. is preparing the 2nd pilot of GlucoPredict ™an AI-powered nutrition education platform developed to assist people check out how food options and part sizes might affect blood sugar before consuming.

The platform utilizes dietary analysis and readily available glucose details to produce approximated post-meal glucose peaks, permitting users to check out possible glucose reactions and compare parts before making food options.

AI-Powered Meal Analysis and Glucose-Peak Estimates

GlucoPredict ™ usages AI-assisted food acknowledgment to recognize meal parts and price quote carbs, proteins, fats, and other dietary info. Its computational design produces an academic glucose-response curve, consisting of an approximated peak after consuming.

Users can picture meals, compare initial and adjusted parts, and check out prospective modifications in approximated glucose actions. Meal history, visual contrasts, and customized PDF reports assist users comprehend their food options and digitally share details with doctor, supporting notified conversations and collective diabetes management.

Culturally Inclusive Nutrition Technology

Acknowledging the connection in between food, culture, and household customs, GlucoPredict ™ supports the analysis of Caribbean, Latin American, Mediterranean, African, Asian, and other foods.

Offered in English, Spanish, French, and Haitian Creole, the platform extends nutrition education to multilingual neighborhoods.

Development Inspired by Experience

GlucoPredict ™ was established by Anna Laudun Beauboeufan expert in psycho-pedagogy with more than 20 years of experience in health care, diabetes client education, and medical practice operations.

Dealing with type 1 diabetes given that youth, Beauboeuf established the principle through individual experience and expert deal with people handling diabetes.

“Living with type 1 diabetes since childhood, I know how overwhelming it can be to manage a condition that never takes a day off. Between insulin adjustments, unexpected highs and lows, and the misconceptions of others, there are moments when you feel lost, misunderstood, or even excluded from the simple joys others take for granted,” stated Beauboeuf. “I created GlucoPredict™ to ease a small part of that burden, helping people feel more informed and confident while enjoying food, family gatherings, and the traditions that bring us together.”

Getting ready for the Second Pilot

Following its preliminary pilot, GlucoPredict ™ is preparing a 2nd examination stage concentrated on meal-analysis efficiency, glucose-response quotes, part contrasts, multilingual ease of access, and user experience.

Feedback from individuals and health care specialists will direct more advancement. The underlying innovation is the topic of a pending patent application.

About Metaboliq, Inc.

Metaboliq, Inc. establishes digital health options concentrated on available, useful, and culturally inclusive nutrition education.

GlucoPredict ™ supplies academic glucose-response price quotes, not direct measurements or medically verified forecasts of specific results. It does not offer insulin dosing suggestions, assistance medical diagnosis or treatment choices, or change expert medical recommendations.

Site: https://www.glucopredict.com


Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND

Subscribe to get the latest posts sent to your email.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Captcha verification failed!
CAPTCHA user score failed. Please contact us!

spot_imgspot_imgspot_imgspot_img